DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Portfolio and Therapeutic Area Strategy

Developing an approach that maximizes the impact of a portfolio of products requires a deep understanding of the dynamics of both the disease area and the industry as a whole. Our extensive knowledge of disease markets, products, and therapeutic categories serve as the foundation for our thorough assessment and construction of your portfolio strategy. Whether your objective is to develop into the market-leader in a therapeutic area or minimize cannibalization across a disease space, our deep understanding of the nuances of therapeutic areas allows us to make recommendations that are realistic, targeted, and data-driven.

 

 

John Lebbos DRG

John Lebbos

Partner DRG Consulting
David Eckford Consultant Decision Resources Group

David Eckford

Partner, DRG Consulting
Adrienne Lovink Partner Decision Resources Group Consulting

Adrienne Lovink

Partner DRG Consulting

Want to see more? Discover the rest of the Consulting Team here.